Great Diamond Partners, LLC Bristol Myers Squibb CO Transaction History

Great Diamond Partners, LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 07, 2024	BUY	$48.48 - $57.85 $17,792 - $21,230	367 Added 9.16%	4,372 $224,000
Q3 2023 Oct 19, 2023	SELL	$57.89 - $64.73 $52,795 - $59,033	-912 Reduced 18.55%	4,005 $232,000
Q2 2023 Jul 17, 2023	BUY	$63.71 - $70.74 $16,437 - $18,250	258 Added 5.54%	4,917 $314,000
Q1 2023 May 04, 2023	BUY	$65.71 - $74.53 $5,651 - $6,409	86 Added 1.88%	4,659 $322,000
Q4 2022 Feb 01, 2023	BUY	$68.48 - $81.09 $2,122 - $2,513	31 Added 0.68%	4,573 $328,000
Q3 2022 Oct 24, 2022	BUY	$0.13 - $76.84 $66 - $39,188	510 Added 12.65%	4,542 $322,000
Q2 2022 Jul 26, 2022	SELL	$72.62 - $79.98 $1,234 - $1,359	-17 Reduced 0.42%	4,032 $310,000
Q1 2022 May 05, 2022	BUY	$61.48 - $73.72 $248,932 - $298,492	4,049 New	4,049 $295,000
Q4 2021 Jan 26, 2022	SELL	$53.63 - $62.52 $222,242 - $259,082	-4,144 Closed	0 $0
Q3 2021 Oct 21, 2021	SELL	$59.17 - $69.31 $18,461 - $21,624	-312 Reduced 7.0%	4,144 $245,000
Q2 2021 Jul 26, 2021	BUY	$61.91 - $67.42 $27,549 - $30,001	445 Added 11.09%	4,456 $297,000
Q1 2021 May 04, 2021	BUY	$59.34 - $66.74 $15,191 - $17,085	256 Added 6.82%	4,011 $253,000
Q4 2020 Jan 26, 2021	BUY	$57.74 - $65.43 $216,813 - $245,689	3,755 New	3,755 $232,000
Q1 2020 May 01, 2020	SELL	$46.4 - $67.43 $174,881 - $254,143	-3,769 Closed	0 $0
Q4 2019 Feb 07, 2020	BUY	$49.21 - $64.19 $185,472 - $241,932	3,769 New	3,769 $241,000

2,533

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $124B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Great Diamond Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Great Diamond Partners, LLC with notifications on news.